Impact BioMedical, Inc. (IBO)
0.5101
-0.05
(-9.19%)
USD |
NYAM |
Dec 24, 16:00
Impact BioMedical Market Cap: 53.37M for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 14.20M |
| AIM ImmunoTech, Inc. | 0.9782M |
| IGC Pharma, Inc. | 28.16M |
| NovaBay Pharmaceuticals, Inc. | 598.55M |
| Protalix Biotherapeutics, Inc. | 142.35M |
Market Cap Related Metrics
| PS Ratio | 244.53 |
| Price | 0.5101 |
| Earnings Yield | -737.0% |